Fulgent Genetics, Inc. (FLGT) stock
FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$24.07−0.59 (-2.37%)
Close on Nov 16, 2026Market cap $662.43MP/E –Yield –
Fulgent Genetics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Fulgent Genetics's profit margin for the twelve months ending Jun 30, 2026 was -26.0%. For fiscal 2025 it was -18.8%, against -15.1% the year before. The highest annual figure on record is 51.1% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -18.8% | −3.7 |
| FY2024 | Dec 31, 2024 | -15.1% | +43.0 |
| FY2023 | Dec 31, 2023 | -58.0% | −81.2 |
| FY2022 | Dec 31, 2022 | 23.2% | −27.9 |
| FY2021 | Dec 31, 2021 | 51.1% | +0.3 |
| FY2020 | Dec 31, 2020 | 50.8% | +52.1 |
| FY2019 | Dec 31, 2019 | -1.3% | +25.0 |
| FY2018 | Dec 31, 2018 | -26.3% | −12.9 |
| FY2017 | Dec 31, 2017 | -13.4% | +15.9 |
| FY2016 | Dec 31, 2016 | -29.3% | +57.6 |
| FY2015 | Dec 31, 2015 | -86.8% | +248.3 |
| FY2014 | Dec 31, 2014 | -335.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -34.6% | −11.4 |
| Q1 FY2026 | Mar 31, 2026 | -34.9% | −19.2 |
| Q4 FY2025 | Dec 31, 2025 | -28.1% | −20.4 |
| Q3 FY2025 | Sep 30, 2025 | -7.9% | +12.6 |
| Q2 FY2025 | Jun 30, 2025 | -23.2% | −10.9 |
| Q1 FY2025 | Mar 31, 2025 | -15.7% | +5.2 |
| Q4 FY2024 | Dec 31, 2024 | -7.7% | +174.0 |
| Q3 FY2024 | Sep 30, 2024 | -20.4% | −4.9 |
| Q2 FY2024 | Jun 30, 2024 | -12.3% | +4.3 |
| Q1 FY2024 | Mar 31, 2024 | -20.9% | +2.3 |
| Q4 FY2023 | Dec 31, 2023 | -181.8% | −146.6 |
| Q3 FY2023 | Sep 30, 2023 | -15.5% | −17.1 |
| Q2 FY2023 | Jun 30, 2023 | -16.5% | −25.8 |
| Q1 FY2023 | Mar 31, 2023 | -23.2% | −71.3 |
| Q4 FY2022 | Dec 31, 2022 | -35.2% | −76.7 |
| Q3 FY2022 | Sep 30, 2022 | 1.6% | −52.1 |
| Q2 FY2022 | Jun 30, 2022 | 9.2% | −42.8 |
| Q1 FY2022 | Mar 31, 2022 | 48.1% | −7.8 |
| Q4 FY2021 | Dec 31, 2021 | 41.5% | −14.9 |
| Q3 FY2021 | Sep 30, 2021 | 53.8% | +7.9 |
| Q2 FY2021 | Jun 30, 2021 | 52.0% | +32.7 |
| Q1 FY2021 | Mar 31, 2021 | 55.8% | +81.1 |
| Q4 FY2020 | Dec 31, 2020 | 56.4% | +59.9 |
| Q3 FY2020 | Sep 30, 2020 | 45.9% | +31.7 |
| Q2 FY2020 | Jun 30, 2020 | 19.2% | +15.3 |
| Q1 FY2020 | Mar 31, 2020 | -25.2% | +10.3 |
| Q4 FY2019 | Dec 31, 2019 | -3.5% | +32.7 |
| Q3 FY2019 | Sep 30, 2019 | 14.1% | +24.7 |
| Q2 FY2019 | Jun 30, 2019 | 3.9% | +23.4 |
| Q1 FY2019 | Mar 31, 2019 | -35.5% | +5.5 |
| Q4 FY2018 | Dec 31, 2018 | -36.2% | +1.7 |
| Q3 FY2018 | Sep 30, 2018 | -10.6% | +13.7 |
| Q2 FY2018 | Jun 30, 2018 | -19.4% | −18.9 |
| Q1 FY2018 | Mar 31, 2018 | -41.0% | −45.4 |
| Q4 FY2017 | Dec 31, 2017 | -37.9% | −51.8 |
| Q3 FY2017 | Sep 30, 2017 | -24.3% | −2.2 |
| Q2 FY2017 | Jun 30, 2017 | -0.5% | – |
| Q1 FY2017 | Mar 31, 2017 | 4.4% | – |
| Q4 FY2016 | Dec 31, 2016 | 13.9% | – |
| Q3 FY2016 | Sep 30, 2016 | -22.1% | – |
See a number that looks wrong?